(19)
(11) EP 4 583 899 A1

(12)

(43) Date of publication:
16.07.2025 Bulletin 2025/29

(21) Application number: 23768649.8

(22) Date of filing: 06.09.2023
(51) International Patent Classification (IPC): 
A61K 38/00(2006.01)
A61K 39/15(2006.01)
A61P 31/12(2006.01)
 A61K 39/12(2006.01)
C07K 14/005(2006.01)
A61P 31/14(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/00; C12N 2720/12134; A61K 2039/552; A61K 2039/55555; C07K 14/005; A61K 39/12; A61K 39/15; A61P 31/12; A61P 31/14; A61K 2039/545; C07K 2319/04; C07K 2319/21; C07K 2319/50
(86) International application number:
PCT/IB2023/058808
(87) International publication number:
WO 2024/052826 (14.03.2024 Gazette 2024/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 06.09.2022 GB 202213002

(71) Applicant: CSIR
0184 Pretoria (ZA)

(72) Inventors:
  • O'KENNEDY, Martha Magaretha
    0184 Pretoria (ZA)
  • LEMMER, Yolandy
    0184 Pretoria (ZA)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) AFRICAN HORSE SICKNESS VIRUS (AHSV) VIRAL PROTEIN 2 (VP2) FUSION PROTEINS